Literature DB >> 21563651

Delayed gastric emptying is related to cardiovascular autonomic neuropathy in Chinese patients with type 2 diabetes.

R W Bian1, Q L Lou, L B Gu, A P Kong, W Y So, G T Ko, X J Ouyang, Y Z Mo, R C Ma, J C Chan, C C Chow.   

Abstract

BACKGROUND AND STUDY AIMS: Delayed gastric emptying (DGE) is the commonest gastrointestinal (GI) complication in type 2 diabetes. We aimed to evaluate the association between DGE and cardiovascular autonomic neuropathy (CAN) in type 2 diabetes. PATIENTS AND METHODS: A total of 71 Chinese patients (39 men and 32 women, aged 60-90 years) and 30 controls (12 men and 18 women, aged 50-79 years) were studied in Nanjing, China. The gastric emptying was assessed by 13C-octanoic acid breath test (OBT) and gastric emptying ultrasonography (GEU). Cardiovascular autonomic neuropathy (CAN) was assessed by a scoring system being validated before.
RESULTS: The diabetic patients, except for a higher plasma glucose level, had similar characteristics compared to the non-diabetic controls. Diabetic patients had higher incidence of DGE and CAN than controls (48.5% vs. 10.7%, p = 0.001). Among diabetic patients with DGE (n = 27), 18 (66.7%) had CAN and 9 (33.3%) did not. Corresponding figures for those without DGE (n = 39) were 14 (35.9%) and 25 (64.1%), respectively (p = 0.014). Diabetes was independently associated with the risk of DGE with odd ratio (95% CI) of 15.6 (1.92, 127.06) (p = 0.010). The presence of diabetes or CAN was independently associated with the half gastric emptying time after adjusting for age, gender, plasma glucose and blood pressure.
CONCLUSIONS: We found a much prolonged gastric emptying time in Chinese patients with type 2 diabetes as compared to non-diabetic controls. There was a high rate of CAN in diabetic patients, and it was associated with gastric emptying.

Entities:  

Mesh:

Year:  2011        PMID: 21563651

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  8 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  The association and interaction analysis of metabolic syndrome and chronic kidney disease on cardiovascular autonomic neuropathy in the general Chinese population.

Authors:  Jin Zhang; Nai-Jia Liu; Yan Zhang; Hong Yang; Zachary Tang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy.

Authors:  X-P Liao; H-W Zhu; F Zeng; Z-H Tang
Journal:  J Endocrinol Invest       Date:  2015-04-23       Impact factor: 4.256

4.  Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people.

Authors:  F Zeng; Z-H Tang; Z Li; X Yu; L Zhou
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

5.  Impact of myenteric plexus alterations on diabetes related gastrointestinal dysmotility.

Authors:  Kyung Sik Park
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

6.  A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.

Authors:  Xiaoli Ge; Shu-Ming Pan; Fangfang Zeng; Zi-Hui Tang; Ying-Wei Wang
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

7.  The analysis of a reference value for baroreflex sensitivity and cardiovascular autonomic neuropathy prevalence in a Chinese population.

Authors:  Zi-Hui Tang; Fangfang Zeng; Kuangping Ye; Xiaoling Yu; Linuo Zhou
Journal:  Eur J Med Res       Date:  2014-02-12       Impact factor: 2.175

8.  Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard.

Authors:  Zi-Hui Tang; Lin Wang; Fangfang Zeng; Zhongtao Li; Xiaoling Yu; Keqin Zhang; Linuo Zhou
Journal:  BMJ Open       Date:  2014-10-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.